Unknown

Dataset Information

0

High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice.


ABSTRACT: PPM1D is a negative regulator of p53 and genomic aberrations resulting in increased activity of PPM1D have been observed in cancers of different origins, indicating that PPM1D has oncogenic properties. We established a transgenic mouse model overexpressing PPM1D and showed that these mice developed a wide variety of cancers. PPM1D-expressing mice developed tumors phenotypically and genetically similar to tumors in mice with dysfunctional p53. T-cell lymphoblastic lymphoma was the most frequent cancer observed in these mice (55%) followed by adenocarcinomas (24%), leukemia (12%) and other solid tumors including neuroblastoma. Characterization of T-cell lymphomas in mice overexpressing PPM1D demonstrates Pten-deletion and p53-accumulation similar to mice with p53 loss-of-function. Also, Notch1 mutations which are recurrently observed in T-cell acute lymphoblastic lymphoma (T-ALL) were frequently detected in PPM1D-transgenic mice. Hence, PPM1D acts as an oncogenic driver in connection with cellular stress, suggesting that the PPM1D gene status and expression levels should be investigated in TP53 wild-type tumors.

SUBMITTER: Milosevic J 

PROVIDER: S-EPMC8582939 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC8130336 | biostudies-literature
| S-EPMC6602201 | biostudies-literature
| S-EPMC8692904 | biostudies-literature
| S-EPMC4073211 | biostudies-literature
| S-EPMC3931745 | biostudies-literature
| S-EPMC6117336 | biostudies-literature
| S-EPMC3653305 | biostudies-literature
| S-EPMC8657050 | biostudies-literature
| S-EPMC10127307 | biostudies-literature
| S-EPMC6900370 | biostudies-literature